← FDA Drug Approvals (Drugs@FDA)
VYEPTI
BLA · Biologics License Application · Sponsor: Lundbeck Seattle BioPharmaceuticals, Inc. · Approved 2020-02-21
Drug application
- FDA Application #
BLA761119- Application type
- Biologics License Application
- Brand name
- VYEPTI
- Generic name
- EPTINEZUMAB-JJMR
- Active ingredients
- EPTINEZUMAB-JJMR
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- Lundbeck Seattle BioPharmaceuticals, Inc.
- Manufacturer
- Lundbeck Pharmaceuticals LLC
- First approval
- 2020-02-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown